Teacher Retirement System of Texas lowered its position in shares of Zoetis Inc. (NYSE:ZTS) by 83.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 34,565 shares of the company’s stock after selling 175,654 shares during the period. Teacher Retirement System of Texas’ holdings in Zoetis were worth $2,156,000 as of its most recent filing with the SEC.
Other large investors have also recently added to or reduced their stakes in the company. BlackRock Inc. raised its stake in Zoetis by 2,471.1% in the first quarter. BlackRock Inc. now owns 36,082,470 shares of the company’s stock worth $1,925,722,000 after buying an additional 34,679,064 shares during the last quarter. Vanguard Group Inc. raised its stake in Zoetis by 1.7% in the first quarter. Vanguard Group Inc. now owns 32,744,421 shares of the company’s stock worth $1,747,570,000 after buying an additional 546,287 shares during the last quarter. State Street Corp raised its stake in Zoetis by 4.9% in the first quarter. State Street Corp now owns 21,256,557 shares of the company’s stock worth $1,134,453,000 after buying an additional 986,680 shares during the last quarter. Morgan Stanley raised its stake in Zoetis by 182.5% in the first quarter. Morgan Stanley now owns 14,617,205 shares of the company’s stock worth $780,119,000 after buying an additional 9,442,207 shares during the last quarter. Finally, Clearbridge Investments LLC raised its stake in Zoetis by 4.2% in the first quarter. Clearbridge Investments LLC now owns 9,254,662 shares of the company’s stock worth $493,921,000 after buying an additional 373,568 shares during the last quarter. 92.70% of the stock is owned by institutional investors and hedge funds.
Shares of Zoetis Inc. (NYSE:ZTS) opened at 60.90 on Friday. The company has a 50 day moving average of $62.00 and a 200-day moving average of $58.20. The firm has a market cap of $29.79 billion, a PE ratio of 34.43 and a beta of 1.02. Zoetis Inc. has a 12-month low of $46.86 and a 12-month high of $63.85.
Zoetis (NYSE:ZTS) last issued its earnings results on Tuesday, August 8th. The company reported $0.53 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.53. Zoetis had a net margin of 17.50% and a return on equity of 62.49%. The company had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same quarter in the previous year, the company earned $0.49 EPS. The firm’s revenue for the quarter was up 5.0% compared to the same quarter last year. Equities research analysts forecast that Zoetis Inc. will post $2.34 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This story was originally posted by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this story on another domain, it was illegally copied and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be read at https://transcriptdaily.com/2017/08/18/zoetis-inc-zts-position-reduced-by-teacher-retirement-system-of-texas.html.
A number of equities research analysts recently weighed in on ZTS shares. Jefferies Group LLC raised their price target on shares of Zoetis from $65.00 to $70.00 and gave the company a “buy” rating in a report on Tuesday, May 9th. Cantor Fitzgerald set a $75.00 price objective on shares of Zoetis and gave the company a “buy” rating in a research note on Monday. Argus reiterated a “buy” rating and set a $69.00 price objective (up from $60.00) on shares of Zoetis in a research note on Tuesday, May 30th. CL King started coverage on shares of Zoetis in a research note on Friday, May 26th. They set a “buy” rating and a $71.00 price objective on the stock. Finally, Deutsche Bank AG reiterated a “buy” rating and set a $65.00 price objective (up from $62.00) on shares of Zoetis in a research note on Monday, July 17th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have issued a buy rating to the company. Zoetis presently has a consensus rating of “Buy” and a consensus price target of $64.78.
Zoetis Company Profile
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS).
Receive News & Ratings for Zoetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc. and related companies with MarketBeat.com's FREE daily email newsletter.